We are excited to announce that Health Through Evidence will be participating in the upcoming ISPOR – International Society for Pharmaceutical Outcomes Research – Europe 2023 conference, to be held in Copenhagen between November 13th and 15th.
Health Through Evidence will be presenting ten research posters, covering a diverse range of diseases. It’s a great honour that one of our posters has been identified as a Top 5% Finalist for the ISPOR Europe 2023 Research Presentation Awards! Additional details about Health Through Evidence research posters and presentation schedules can be found below.
Monday 13 November 2023 | |||
1)Title | Cost-Effectiveness Analysis of Pemigatinib for the Treatment of Adult Patients with Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement That Have Progressed After Systemic Therapy in Greece. | ||
Authors: | Tzanetakos C, Psarra M, Batsi M, Patterson K, Vostitsanou Z, Gourzoulidis G | ||
Poster Session Time: | 10:30 – 13:30 | ||
Discussion Period: | 12:30 – 13:30 | ||
Find out more at: | Study Link | ||
2)Title | Cost Analysis of Managing Brain Metastases in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer in Greece. | ||
Authors: | Zisimopoulou O, Liavas A, Tzanetakos C, Gourzoulidis G | ||
Poster Session Time: | 10:30 – 13:30 | ||
Discussion Period: | 12:30 – 13:30 | ||
Find out more at: | Study Link | ||
3)Title | Cost-Effectiveness Analysis of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece. | ||
Authors: | Gourzoulidis G, Solakidi A, Psarra M, Nikitopoulou E, Tzanetakos C | ||
Poster Session Time: | 10:30 – 13:30 | ||
Discussion Period: | 12:30 – 13:30 | ||
Find out more at: | Study Link | ||
4)Title | Economic Evaluation of Tofacitinib for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis in Greece. | ||
Authors: | Tzanetakos C, Solakidi A, Psarra M, Nikitopoulou E, Gourzoulidis G | ||
Poster Session Time: | 15:30 – 18:30 | ||
Discussion Period: | 16:00 – 17:00 | ||
Find out more at: | Study Link | ||
5)Title | Cost-Effectiveness Analysis of Upadacitinib in Patients with Active Non-Radiographic Axial Spondyloarthritis in Greece. | ||
Authors: | Tzanetakos C, Kotsis I, Gourzoulidis G | ||
Poster Session Time: | 15:30 – 18:30 | ||
Discussion Period: | 16:00 – 17:00 | ||
Find out more at: | Study Link | ||
6)Title | Lorlatinib as a First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer: Cost-Effectiveness Analysis in Greece | ||
Authors: | Gourzoulidis G Zisimopoulou O, Liavas A, Tzanetakos C | ||
Poster Session Time: | Study Link | ||
Discussion Period: | 15:30 – 18:30 | ||
Find out more at: | 16:00 – 17:00 | ||
Tuesday 14 November 2023 | |||
7)Title | Setting Treatment Selection Criteria for Breast Cancer From a Clinician Perspective: Is It a Matter of Cost? | ||
Authors: | Gourzoulidis G, Balasopoulos A, Chaviara E, Savourdos P, Tzanetakos C | ||
Poster Session Time: | 10:30 – 13:30 | ||
Discussion Period: | 12:30 – 13:30 | ||
Find out more at: | Study Link | ||
8)Title | Cost-Effectiveness Analysis of Upadacitinib in Patients with Moderately to Severely Active Ulcerative Colitis in Greece.
Top 5% Finalist for the ISPOR Europe 2023 Research Presentation Awards 🏅 |
||
Authors: | Tzanetakos C, Psarra M, Kotsis I, Gourzoulidis G | ||
Poster Session Time: | 15:30 – 18:30 | ||
Discussion Period: | 16:00 – 17:00 | ||
Find out more at: | Study Link | ||
9)Title | Quality of Life and Duchenne Muscular Dystrophy: Greek Translation of the Pediatric Quality of Life Inventory (PEDSQL)3.0 Duchenne Muscular Dystrophy Module. | ||
Authors: | Katsomiti E, Kastanioti C, Chroni E, Mavridoglou G, Douka A, Karras A, Gourzoulidis G | ||
Poster Session Time: | 15:30 – 18:30 | ||
Discussion Period: | 16:00 – 17:00 | ||
Find out more at: | Study Link | ||
10)Title | Beyond the Hospital Walls: Hospital at Home Programs for Cancer Patients Worldwide and the Road to Implementation in Greece. | ||
Authors: | Braoudaki E, Gkioka V, Balaoura O, Tzanetakos C, Gourzoulidis G | ||
Poster Session Time: | 15:30 – 18:30 | ||
Discussion Period: | 16:00 – 17:00 | ||
Find out more at: |
Study Link |
ISPOR conferences are always a great opportunity to meet friends, make new connections and share our latest news and developments. We look forward to seeing you there!
Learn more about our services at www.hte.gr or request a meeting with our expert at info@hte.gr